In a significant move, Canada has permitted the possession of hallucinogenic mushrooms for therapeutic applications. Individuals experiencing by psychological conditions, like sadness and nervousness, can potentially obtain therapy through approved centers. This policy marks a major change in Canada's perspective to psychiatric care and reflects a